A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

BACKGROUND: Preclinical studies suggest that interleukin-9 may be a central mediator in the development and maintenance of airway inflammation in asthma. The aim of this study was therefore to evaluate the effects of MEDI-528, an anti-interleukin-9 monoclonal antibody, in adults with confirmed uncon...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Chad K, Leigh, Richard, McLaurin, Kimmie K, Kim, Keunpyo, Hultquist, Micki, Molfino, Nestor A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848834/
https://www.ncbi.nlm.nih.gov/pubmed/24050312
http://dx.doi.org/10.1186/1465-9921-14-93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848834/
https://www.ncbi.nlm.nih.gov/pubmed/24050312
http://dx.doi.org/10.1186/1465-9921-14-93

Ejemplares similares